Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells

Journal of General Virology

Volumn 90, Issue 5, 2009, Pages 1124-1134

  Liao, Fu Tien ^a   Lee, Yi Ju ^a   Ko, Jiunn Liang ^a   Tsai, Chu Cheng ^a   Tseng, Chao Jung ^a   Sheu, Gwo Tarng ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; DOXORUBICIN; HEPATITIS DELTA ANTIGEN; HISTONE H3; ANTINEOPLASTIC ANTIBIOTIC; CLU PROTEIN, HUMAN; HISTONE;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE SEVERITY; EPIGENETICS; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSFECTION; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; VIRUS REPLICATION; DRUG RESISTANCE; GENETIC EPIGENESIS; GENETICS; LIVER TUMOR; METABOLISM; PHYSIOLOGY; TIME; TUMOR CELL LINE;

HEPATITIS DELTA VIRUS;

ACETYLATION; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CLUSTERIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS DELTA VIRUS; HISTONES; HUMANS; LIVER NEOPLASMS; TIME FACTORS; VIRUS REPLICATION;

EID: 67449092556     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.007211-0     Document Type: Article

References (41)

1. Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I. & Knowles, B. B. (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282, 615-616.
2. Blaschuk, O., Burdzy, K. & Fritz, I. B. (1983). Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 258, 7714-7720.
3. Bonino, F., Heermann, K. H., Rizzetto, M. & Gerlich, W. H. (1986). Hepatitis delta virus: Protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol 58, 945-950.
4. Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J. & Kouzarides, T. (1999). The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 18, 2449-2458.
5. Buti, M., Estebán, R., Jardi, R., Allende, H., Estebán, J. I., Genesca, J. & Guardia, J. (1987). Clinical and serological outcome of acute delta infection. J Hepatol 5, 59-64.
6. Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y. & Evans, R. M. (1999). A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403.
7. Chang, F. L., Chen, P. J., Tu, S. J., Wang, C. J. & Chen, D. S. (1991). The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A 88, 8490-8494.
8. Chang, J. T., Chang, G. C., Ko, J. L., Liao, H. Y., Liu, H. J., Chen, C. C., Su, J. M., Lee, H. & Sheu, G. T. (2006). Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines. Int J Cancer 118, 317-325.
9. Choi, S. H., Jeong, S. H. & Hwang, S. B. (2007). Large hepatitis delta antigen modulates transforming growth factor-β signaling cascades: Implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 132, 343-357.
10. Choi-Miura, N. H., Takahashi, Y., Nakano, Y., Tobe, T. & Tomita, M. (1992). Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). J Biochem 112, 557-561.
11. Colombo, M., Cambieri, R., Rumi, M. G., Ronchi, G., Del Ninno, E. & De Franchis, R. (1983). Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 85, 235-239.
12. Criswell, T., Klokov, D., Beman, M., Lavik, J. P. & Boothman, D. A. (2003). Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol Ther 2, 372-380.
13. Fattovich, G., Boscaro, S., Noventa, F., Pornaro, E., Stenico, D., Alberti, A., Ruol, A. & Realdi, G. (1987). Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 155, 931-935.
14. Feng, J. T., Liu, Y. K., Song, H. Y., Dai, Z., Qin, L. X., Almofti, M. R., Fang, C. Y., Lu, H. J., Yang, P. Y. & Tang, Z. Y. (2005). Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5, 4581-4588.
15. Goto, T., Kato, N., Ono-Nita, S. K., Yoshida, H., Otsuka, M., Shiratori, Y. & Omata, M. (2000). Large isoform of hepatitis delta antigen activates serum response factor-associated transcription. J Biol Chem 275, 37311-37316.
16. Gray, S. G. & Teh, B. T. (2001). Histone acetylation/ deacetylation and cancer: An "open" and "shut" case? Curr Mol Med 1, 401-429.
17. Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H. Y., Wang, J. Y., Nakatani, Y. & Kedes, L. (1999). Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413.
18. Huang, W. H., Yung, B. Y., Syu, W. J. & Lee, Y. H. (2001). The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem 276, 25166-25175.
19. Huang, W. H., Mai, R. T. & Lee, Y. H. (2008). Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication. J Virol 82, 7313-7324.
20. Kang, Y. K., Hong, S. W., Lee, H. & Kim, W. H. (2004). Overexpression of clusterin in human hepatocellular carcinoma. Hum Pathol 35, 1340-1346.
21. Kim, Y. J., Kwak, C. I., Gu, Y. Y., Hwang, I. T. & Chun, J. Y. (2004). Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 36, 424-426, 428, 430 passim.
22. Lau, S. H., Sham, J. S., Xie, D., Tzang, C. H., Tang, D., Ma, N., Hu, L., Wang, Y.,Wen, J. M. & other authors (2006). Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25, 1242-1250.
23. Lee, C. Z. & Sheu, J. C. (2008). Histone H1e interacts with small hepatitis delta antigen and affects hepatitis delta virus replication. Virology 375, 197-204.
24. Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. & Boothman, D. A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278, 11590-11600.
25. Loison, F., Debure, L., Nizard, P., le Goff, P., Michel, D. & le Dréan, Y. (2006). Up-regulation of the clusterin gene after proteotoxic stress: Implication of HSF1-HSF2 heterocomplexes. Biochem J 395, 223-231.
26. Lund, P., Weisshaupt, K., Mikeska, T., Jammas, D., Chen, X., Kuban, R. J., Ungethüm, U., Krapfenbauer, U., Herzel, H. P. & other authors (2006). Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene 25, 4890-4903.
27. Michel, D., Chatelain, G., North, S. & Brun, G. (1997). Stress-induced transcription of the clusterinapoJ gene. Biochem J 328, 45-50.
28. Miyake, H., Hara, I., Fujisawa, M. & Gleave, M. E. (2006). The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer. Expert Opin Investig Drugs 15, 507-517.
29. Nuutinen, T., Suuronen, T., Kyrylenko, S., Huuskonen, J. & Salminen, A. (2005). Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells. Neurochem Int 47, 528-538.
30. Oliveri, F., Brunetto, M. R., Actis, G. C. & Bonino, F. (1991). Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC). Ital J Gastroenterol 23, 498-502.
31. Polson, A. G., Bass, B. L. & Casey, J. L. (1996). RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380, 454-456.
32. Rizzetto, M., Shih, J. W., Gocke, D. J., Purcell, R. H., Verme, G. & Gerin, J. L. (1979). Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet 2, 986-990.
33. Sheu, G. T. (2002). Initiation of hepatitis delta virus (HDV) replication: HDV RNA encoding the large delta antigen cannot replicate. J Gen Virol 83, 2507-2513.
34. Sheu, G. T. & Lai, M. M. (2000). Recombinant hepatitis delta antigen from E. coli promotes hepatitis delta virus RNA replication only from the genomic strand but not the antigenomic strand. Virology 278, 578-586.
35. Smedile, A., Farci, P., Verme, G., Caredda, F., Cargnel, A., Caporaso, N., Dentico, P., Trepo, C., Opolon, P. & other authors (1982). Influence of delta infection on severity of hepatitis B. Lancet 2, 945-947.
36. Trougakos, I. P. & Gonos, E. S. (2002). Clusterin/ apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34, 1430-1448.
37. Trougakos, I. P. & Gonos, E. S. (2006). Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 40, 1324-1334.
38. Valls, E., de la Cruz, X. & Martínez-Balbás, M. A. (2003). The SV40 T antigen modulates CBP histone acetyltransferase activity. Nucleic Acids Res 31, 3114-3122.
39. Verme, G., Brunetto, M. R., Oliveri, F., Baldi, M., Forzani, B., Piantino, P., Ponzetto, A. & Bonino, F. (1991). Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci 36, 1134-1136.
40. Waris, G. & Siddiqui, A. (2003). Regulatory mechanisms of viral hepatitis B and C. J Biosci 28, 311-321.
41. Wei, Y. & Ganem, D. (1998). Activation of heterologous gene expression by the large isoform of hepatitis delta antigen. J Virol 72, 2089-2096.